Chester County News and Community Website
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has released its financial results for the third quarter of 2024, alongside updates on significant developments, particularly concerning its lead product candidate, INO-3107. …
INOVIO Reports Third-Quarter Financial Results and Updates on INO-3107 Progress Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has unveiled encouraging new immunology data for its lead product candidate, INO-3107, which is designed to treat recurrent respiratory papillomatosis (RRP), a condition caused …
INOVIO Announces Promising Immunology Data for INO-3107 in RRP Treatment Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced new data for its leading candidate, INO-3107, which could transform the treatment of recurrent respiratory papillomatosis (RRP). These findings, shared at the …
INOVIO Unveils Promising Data for INO-3107 in Treating RRP Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has recently issued equity grants to new employees as part of its 2022 Inducement Plan. Aimed at attracting top talent, these inducement grants are …
INOVIO Announces Equity Grants for New Employees Under 2022 Inducement Plan Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced its financial results for the second quarter of 2024 and provided an update on recent company developments. The company highlighted progress on …
INOVIO Reports Q2 2024 Financial Results and Provides Business Update Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has announced a significant milestone for its lead candidate, INO-3107, aimed at treating Recurrent Respiratory Papillomatosis (RRP). The European Medicines Agency’s Committee for …
INOVIO’s INO-3107 Receives European Certification for Quality and Data Compliance Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that its lead DNA medicine candidate, INO-3107, has been granted an Innovation Passport by the U.K.’s Innovative Licensing and Access Pathway (ILAP). …
INOVIO’s DNA Medicine INO-3107 Receives U.K. Innovation Passport Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has appointed Steven Egge as Chief Commercial Officer. Mr. Egge will spearhead the company’s commercial strategy and operations as it gears up for …
INOVIO Appoints Steven Egge as Chief Commercial Officer Amid Launch Preparations Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced this week the issuance of an equity grant to a newly hired employee under its 2022 Inducement Plan. The move aims to …
INOVIO Grants Equity Award to New Hire Under Inducement Plan Read More PLYMOUTH MEETING, PA — Biotechnology firm INOVIO (NASDAQ: INO) has been readded to the Russell 2000® Index as part of the annual reconstitution of the Russell stock indexes. This change …
INOVIO Rejoins Russell 2000 Index, Signals Progress in Biotech Advancements Read More